NK cell-mediated lysis is essential to kill Epstein–Barr virus transformed lymphoblastoid B cells when using rituximab

Published 2008 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
NK cell-mediated lysis is essential to kill Epstein–Barr virus transformed lymphoblastoid B cells when using rituximab
Authors
Keywords
-
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 63, Issue 6, Pages 413-420
Publisher
Elsevier BV
Online
2008-10-02
DOI
10.1016/j.biopha.2008.08.009

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.